Labat Africa Ltd

JSE:LAB South Africa Drug Manufacturers - Specialty & Generic
Market Cap
$4.42 Million
ZAC8.33 Billion ZAC
Market Cap Rank
#42524 Global
#185 in South Africa
Share Price
ZAC5.00
Change (1 day)
+0.00%
52-Week Range
ZAC4.00 - ZAC9.00
All Time High
ZAC155.00
About

Labat Africa Limited, an investment holding company, engages in the technology, logistics, and healthcare activities in South Africa. The company operates through Technology, Logistics, and Healthcare segments. It engages in the manufacture and distribution of integrated circuits, including micro electronic systems; transportation of coals and minerals for mines; and sale of medical cannabis, as … Read more

Labat Africa Ltd (LAB) - Net Assets

Latest net assets as of November 2025: ZAC313.79 Million ZAC

Based on the latest financial reports, Labat Africa Ltd (LAB) has net assets worth ZAC313.79 Million ZAC as of November 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ZAC769.82 Million) and total liabilities (ZAC456.03 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets ZAC313.79 Million
% of Total Assets 40.76%
Annual Growth Rate 2.03%
5-Year Change 144.22%
10-Year Change 3633.93%
Growth Volatility 228.3

Labat Africa Ltd - Net Assets Trend (2002–2025)

This chart illustrates how Labat Africa Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Labat Africa Ltd (2002–2025)

The table below shows the annual net assets of Labat Africa Ltd from 2002 to 2025.

Year Net Assets Change
2025-08-31 ZAC247.41 Million +1371.81%
2024-08-31 ZAC-19.45 Million -298.72%
2023-08-31 ZAC9.79 Million -88.68%
2022-08-31 ZAC86.45 Million -14.66%
2021-08-31 ZAC101.31 Million +33.36%
2020-08-31 ZAC75.96 Million +320.60%
2019-08-31 ZAC-34.43 Million -238.67%
2018-08-31 ZAC24.83 Million +102.76%
2017-08-31 ZAC12.25 Million +84.82%
2016-08-31 ZAC6.63 Million +413.72%
2015-08-31 ZAC-2.11 Million -569.51%
2014-08-31 ZAC449.83K +105.24%
2013-08-31 ZAC-8.58 Million -722.69%
2012-08-31 ZAC1.38 Million -36.73%
2011-08-31 ZAC2.18 Million +108.68%
2010-08-31 ZAC-25.09 Million +31.38%
2009-08-31 ZAC-36.57 Million -197.19%
2006-08-31 ZAC37.62 Million -42.73%
2005-08-31 ZAC65.70 Million -16.27%
2004-08-31 ZAC78.46 Million -45.41%
2003-08-31 ZAC143.72 Million -7.85%
2002-08-31 ZAC155.95 Million --

Equity Component Analysis

This analysis shows how different components contribute to Labat Africa Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 15384700000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (August 2025)

Component Amount Percentage
Common Stock ZAC220.78 Million 151.39%
Other Components ZAC78.90 Million 54.10%
Total Equity ZAC145.84 Million 100.00%

Labat Africa Ltd Competitors by Market Cap

The table below lists competitors of Labat Africa Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Labat Africa Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -23,800,000 to 145,840,000, a change of 169,640,000.
  • Net income of 117,867,000 contributed positively to equity growth.
  • Other factors increased equity by 51,773,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income ZAC117.87 Million +80.82%
Other Changes ZAC51.77 Million +35.5%
Total Change ZAC- %

Book Value vs Market Value Analysis

This analysis compares Labat Africa Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 38.16x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 6.10x to 38.16x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-08-31 ZAC0.82 ZAC5.00 x
2003-08-31 ZAC0.75 ZAC5.00 x
2004-08-31 ZAC0.38 ZAC5.00 x
2005-08-31 ZAC0.27 ZAC5.00 x
2006-08-31 ZAC0.13 ZAC5.00 x
2009-08-31 ZAC-0.19 ZAC5.00 x
2010-08-31 ZAC-0.13 ZAC5.00 x
2011-08-31 ZAC0.01 ZAC5.00 x
2012-08-31 ZAC0.01 ZAC5.00 x
2013-08-31 ZAC-0.04 ZAC5.00 x
2014-08-31 ZAC0.00 ZAC5.00 x
2016-08-31 ZAC0.03 ZAC5.00 x
2017-08-31 ZAC0.05 ZAC5.00 x
2018-08-31 ZAC0.10 ZAC5.00 x
2019-08-31 ZAC-0.12 ZAC5.00 x
2020-08-31 ZAC0.21 ZAC5.00 x
2021-08-31 ZAC0.23 ZAC5.00 x
2022-08-31 ZAC0.15 ZAC5.00 x
2023-08-31 ZAC0.00 ZAC5.00 x
2024-08-31 ZAC-0.04 ZAC5.00 x
2025-08-31 ZAC0.13 ZAC5.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Labat Africa Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 80.82%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 59.11%
  • • Asset Turnover: 0.30x
  • • Equity Multiplier: 4.63x
  • Recent ROE (80.82%) is above the historical average (-890.21%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 20.05% 12.41% 0.88x 1.84x ZAC15.24 Million
2003 -9.85% -7.77% 0.65x 1.96x ZAC-27.50 Million
2004 -90.08% -32.47% 0.85x 3.27x ZAC-69.93 Million
2005 -39.17% -12.34% 0.90x 3.54x ZAC-24.17 Million
2006 -264.88% -39.77% 0.78x 8.59x ZAC-67.38 Million
2009 0.00% -123.73% 0.49x 0.00x ZAC-31.12 Million
2010 0.00% 38.36% 0.63x 0.00x ZAC13.98 Million
2011 1177.04% 164.93% 0.31x 23.35x ZAC25.42 Million
2012 -65.17% -6.78% 0.38x 25.13x ZAC-1.04 Million
2013 0.00% -36.29% 0.37x 0.00x ZAC-2.75 Million
2014 316.70% 11.75% 0.55x 48.87x ZAC1.38 Million
2015 0.00% -34.34% 0.69x 0.00x ZAC-4.91 Million
2016 126.72% 58.67% 0.61x 3.55x ZAC7.73 Million
2017 37.90% 8.92% 1.13x 3.74x ZAC3.42 Million
2018 50.68% 17.16% 1.17x 2.53x ZAC10.10 Million
2019 0.00% -11.83% 3.14x 0.00x ZAC-69.50 Million
2020 1.36% 2.35% 0.21x 2.72x ZAC-6.03 Million
2021 -24.84% -77.74% 0.13x 2.43x ZAC-31.91 Million
2022 -62.28% -156.59% 0.15x 2.69x ZAC-55.84 Million
2023 -20839.57% -175.44% 0.37x 318.79x ZAC-86.94 Million
2024 0.00% -53.16% 0.39x 0.00x ZAC-23.42 Million
2025 80.82% 59.11% 0.30x 4.63x ZAC103.28 Million

Industry Comparison

This section compares Labat Africa Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $14,464,090,236
  • Average return on equity (ROE) among peers: 9.11%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Labat Africa Ltd (LAB) ZAC313.79 Million 20.05% 1.45x $44.25K
Aspen Pharmacare Holdings Ltd (APN) $28.88 Billion 17.34% 1.86x $27.13 Million
CCC (CCC) $52.08 Million 0.87% 0.21x $24.72 Million